Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-04-23

Clinical Trial Update: Immunosuppression in HIV-infected Patients With Tuberculosis in Ethiopia

View source ↗

Summary

A completed Lund University–sponsored clinical trial in Ethiopia investigated immunosuppression in HIV-infected patients with tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Lund University | Conditions: HIV Infection, Tuberculosis | Status: COMPLETED